115 related articles for article (PubMed ID: 10808578)
1. [The antibacterial resistance of the strains making up the components of probiotic preparations].
Lykova EA
Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):63-6. PubMed ID: 10808578
[TBL] [Abstract][Full Text] [Related]
2. [Intestinal dysbacteriosis in antibacterial therapy and perspectives in treatment by antibiotic-resistant probiotics].
Lykova EA
Antibiot Khimioter; 2001; 46(3):21-5. PubMed ID: 11548277
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
Zhou JS; Pillidge CJ; Gopal PK; Gill HS
Int J Food Microbiol; 2005 Feb; 98(2):211-7. PubMed ID: 15681048
[TBL] [Abstract][Full Text] [Related]
4. [The primary screening of bifidobacteria and lactobacilli strains to develop effective probiotic preparations based on them].
Pikina AP; Smeianov VV; Efimov BA; Baĭnov NA; Brook I; Reeves G; Korshunov VM
Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):34-8. PubMed ID: 10876846
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products.
D'Aimmo MR; Modesto M; Biavati B
Int J Food Microbiol; 2007 Apr; 115(1):35-42. PubMed ID: 17198739
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract.
Delgado S; Flórez AB; Mayo B
Curr Microbiol; 2005 Apr; 50(4):202-7. PubMed ID: 15902467
[TBL] [Abstract][Full Text] [Related]
8. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.
Sikorska H; Smoragiewicz W
Int J Antimicrob Agents; 2013 Dec; 42(6):475-81. PubMed ID: 24071026
[TBL] [Abstract][Full Text] [Related]
9. Effect of conjugated bile salts on antibiotic susceptibility of bile salt-tolerant Lactobacillus and Bifidobacterium isolates.
Charteris WP; Kelly PM; Morelli L; Collins JK
J Food Prot; 2000 Oct; 63(10):1369-76. PubMed ID: 11041136
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of faecal bifidobacteria and lactobacilli isolated from dogs and primates.
Strompfová V; Lauková A
Anaerobe; 2014 Oct; 29():108-12. PubMed ID: 24239978
[TBL] [Abstract][Full Text] [Related]
11. Characterization of antimicrobial resistance in lactobacilli and bifidobacteria used as probiotics or starter cultures based on integration of phenotypic and in silico data.
Rozman V; Mohar Lorbeg P; Accetto T; Bogovič Matijašić B
Int J Food Microbiol; 2020 Feb; 314():108388. PubMed ID: 31707173
[TBL] [Abstract][Full Text] [Related]
12. Microbiological Cutoff Values: A Critical Issue in Phenotypic Antibiotic Resistance Assessment of Lactobacilli and Bifidobacteria.
Połka J; Morelli L; Patrone V
Microb Drug Resist; 2016 Dec; 22(8):696-699. PubMed ID: 27030947
[TBL] [Abstract][Full Text] [Related]
13. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells.
Čitar M; Hacin B; Tompa G; Štempelj M; Rogelj I; Dolinšek J; Narat M; Matijašić BB
Benef Microbes; 2015; 6(3):325-36. PubMed ID: 25391349
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?
Neut C; Mahieux S; Dubreuil LJ
Med Mal Infect; 2017 Nov; 47(7):477-483. PubMed ID: 28797834
[TBL] [Abstract][Full Text] [Related]
15. [Estimation of Probiotic Lactobacilli Drug Resistance].
Bruslik NL; Akhatova DR; Toimentseva AA; Abdulkhakov SR; Ilyinskaya ON; Yarullina DR
Antibiot Khimioter; 2015; 60(3-4):6-13. PubMed ID: 26415377
[TBL] [Abstract][Full Text] [Related]
16. [Probiotic properties of industrial strains of lactobacilli and bifidobacteria].
Kovalenko NK; Livins'ka OP; Poltavs'ka OA; Harmasheva IL; Shynkarenko LM; Oleshchenko LT
Mikrobiol Z; 2010; 72(1):9-17. PubMed ID: 20364710
[TBL] [Abstract][Full Text] [Related]
17. Towards effective and stable probiotics.
Yarullina DR; Damshkaln LG; Bruslik NL; Konovalova OA; Ilinskaya ON; Lozinsky VI
Int J Risk Saf Med; 2015; 27 Suppl 1():S65-6. PubMed ID: 26639716
[TBL] [Abstract][Full Text] [Related]
18. Safety of probiotics that contain lactobacilli or bifidobacteria.
Borriello SP; Hammes WP; Holzapfel W; Marteau P; Schrezenmeir J; Vaara M; Valtonen V
Clin Infect Dis; 2003 Mar; 36(6):775-80. PubMed ID: 12627362
[TBL] [Abstract][Full Text] [Related]
19. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
Saarela M; Maukonen J; von Wright A; Vilpponen-Salmela T; Patterson AJ; Scott KP; Hämynen H; Mättö J
Int J Antimicrob Agents; 2007 Mar; 29(3):271-80. PubMed ID: 17207972
[TBL] [Abstract][Full Text] [Related]
20. Identification and antibiotic susceptibility of bacterial isolates from probiotic products available in Italy.
Milazzo I; Speciale A; Musumeci R; Fazio D; Blandino G
New Microbiol; 2006 Oct; 29(4):281-91. PubMed ID: 17201095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
